UMeWorld Limited Outlines Strategy 2026: Scaling Global Biofuel Infrastructure and Functional Nutrition Platforms GlobeNewswire January 06, 2026 MIAMI, Jan. 06, 2026 (GLOBE NEWSWIRE) — UMeWorld Limited (OTC: UMEWF), a Delaware-incorporated company advancing enzymatic biorefining solutions for renewable fuels and functional nutrition, today announced Strategy 2026, outlining its transition from technology validation to disciplined, industrial-scale commercialization […]

Mobix Labs, Inc. Announces Pricing of $6.0 Million Oversubscribed Public Offering of Common Stock to Fast-Track Aggressive Growth Strategy GlobeNewswire January 06, 2026 IRVINE, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) — Mobix Labs, Inc. (Nasdaq: MOBX, “Mobix Labs” or the “Company”), a leading provider of advanced connectivity solutions, today announced the pricing of its previously

Kahuna Labs Appoints Atul Nanda as Executive Advisor to Guide Product Strategy and Support Industry Engagement GlobeNewswire January 06, 2026 SAN JOSE, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) — Kahuna Labs, the Frontline Productivity Company, today announced that Atul Nanda has joined the company as an Executive Advisor, bringing decades of global leadership experience across

ZenaTech's ZenaDrone Subsidiary Positioned for U.S. Defense and Government Demand for NDAA-Compliant Drones from Recent FCC Public Notice GlobeNewswire January 06, 2026 VANCOUVER, British Columbia, Jan. 06, 2026 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS),

Aeromexico December 2025 Traffic Results GlobeNewswire January 06, 2026 MEXICO CITY, Jan. 06, 2026 (GLOBE NEWSWIRE) — Grupo Aeromexico S.A.B. de C.V. (NYSE: AERO & BMV: AERO) (“Aeromexico”) reports its December 2025 operational results: Grupo Aeromexico transported 2 million and 180 thousand passengers in December 2025, a 0.4% year-over-year increase. International passengers increased by 2.7%,

Denali Therapeutics Announces Key Anticipated Milestones and Priorities for 2026 Including Commercial Launch of Tividenofusp Alfa for Hunter Syndrome GlobeNewswire January 06, 2026 Preparing for FDA approval and commercial launch of tividenofusp alfa, Denali's TransportVehicle(TM) (TV)-enabled investigational therapy for Hunter syndrome Expecting multiple clinical data readouts from pipeline programs including for Sanfilippo syndrome Type A

Zentalis Pharmaceuticals Provides Corporate Update and Highlights Key Milestones and Expected Momentum in the Azenosertib Development Program for 2026 GlobeNewswire January 06, 2026 Completed enrollment in DENALI Part 2a; dose confirmation expected in 1H 2026 DENALI Part 2 trial topline readout expected by year end 2026; potential to support accelerated approval Initiation of the ASPENOVA

Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S. Fourth major national payer releases positive comprehensive coverage for AI-powered Heartflow Plaque Analysis GlobeNewswire January 06, 2026 MOUNTAIN VIEW, Calif., Jan. 06, 2026 (GLOBE NEWSWIRE) — Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI

Brane Audio Unveils RAD2 at CES 2026: The Next Major Advancement in Sub-Bass Technology RAD2 delivers a 30-fold advantage in deep bass sound production and will power the next generation of Brane Audio speakers GlobeNewswire January 06, 2026 Las Vegas, Jan. 06, 2026 (GLOBE NEWSWIRE) — Key Highlights Brane Audio debuts RAD2, the most efficient

Galecto Announces Key Additions to Leadership Team GlobeNewswire January 06, 2026 Deep hematology/oncology drug development experience added with the appointment of Sherwin Sattarzadeh as Chief Operating Officer and Becker Hewes as Chief Medical Officer DMR-001, a potentially best-in-class mutant calreticulin (“mutCALR”) targeting monoclonal antibody, on track for IND submission in mid-2026 with anticipated first-in-human dosing